Mark F. Vickers

947 total citations
15 papers, 784 citations indexed

About

Mark F. Vickers is a scholar working on Physiology, Molecular Biology and Biochemistry. According to data from OpenAlex, Mark F. Vickers has authored 15 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 7 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in Mark F. Vickers's work include Adenosine and Purinergic Signaling (13 papers), Amino Acid Enzymes and Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Mark F. Vickers is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Amino Acid Enzymes and Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Mark F. Vickers collaborates with scholars based in Canada, United Kingdom and United States. Mark F. Vickers's co-authors include Carol E. Cass, James D. Young, Stephen A. Baldwin, Amy M.L. Ng, Sylvia Y.M. Yao, Manickavasagam Sundaram, Frank Visser, Douglas L. Hogue, Rajam S. Mani and Jing Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Mark F. Vickers

15 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark F. Vickers Canada 11 504 282 216 175 130 15 784
Kyla M. Smith Canada 15 447 0.9× 238 0.8× 268 1.2× 147 0.8× 118 0.9× 19 755
Manickavasagam Sundaram United Kingdom 12 650 1.3× 393 1.4× 279 1.3× 197 1.1× 125 1.0× 17 1.1k
Song Yao Canada 9 317 0.6× 181 0.6× 203 0.9× 117 0.7× 78 0.6× 11 619
Pat Carpenter Canada 7 232 0.5× 132 0.5× 162 0.8× 76 0.4× 44 0.3× 7 408
Isabel Huber‐Ruano Spain 11 98 0.2× 166 0.6× 110 0.5× 70 0.4× 23 0.2× 15 401
Jeffrey M. Chinsky United States 16 88 0.2× 516 1.8× 66 0.3× 51 0.3× 117 0.9× 38 912
L. J. M. Spaapen Netherlands 15 59 0.1× 492 1.7× 17 0.1× 29 0.2× 81 0.6× 37 780
Hiromu Nishihara Japan 9 119 0.2× 215 0.8× 138 0.6× 22 0.1× 45 0.3× 11 481
Christof Ludescher Austria 14 15 0.0× 236 0.8× 393 1.8× 100 0.6× 11 0.1× 26 714
Raquel Dodelson de Kremer Argentina 17 26 0.1× 395 1.4× 18 0.1× 51 0.3× 36 0.3× 52 735

Countries citing papers authored by Mark F. Vickers

Since Specialization
Citations

This map shows the geographic impact of Mark F. Vickers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark F. Vickers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark F. Vickers more than expected).

Fields of papers citing papers by Mark F. Vickers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark F. Vickers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark F. Vickers. The network helps show where Mark F. Vickers may publish in the future.

Co-authorship network of co-authors of Mark F. Vickers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark F. Vickers. A scholar is included among the top collaborators of Mark F. Vickers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark F. Vickers. Mark F. Vickers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Vickers, Mark F., Jing Zhang, Frank Visser, et al.. (2004). Uridine Recognition Motifs of Human Equilibrative Nucleoside Transporters 1 and 2 Produced in Saccharomyces cerevisiae. Nucleosides Nucleotides & Nucleic Acids. 23(1-2). 361–373. 37 indexed citations
3.
Zhang, Jing, Frank Visser, Mark F. Vickers, et al.. (2003). Uridine Binding Motifs of Human Concentrative Nucleoside Transporters 1 and 3 Produced in Saccharomyces cerevisiae. Molecular Pharmacology. 64(6). 1512–1520. 52 indexed citations
4.
Visser, Frank, Mark F. Vickers, Amy M.L. Ng, et al.. (2002). Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole. Journal of Biological Chemistry. 277(1). 395–401. 110 indexed citations
5.
Vickers, Mark F., Rakesh Kumar, Frank Visser, et al.. (2002). Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochemistry and Cell Biology. 80(5). 639–644. 39 indexed citations
6.
Cass, Carol E., James D. Young, Stephen A. Baldwin, et al.. (2002). Nucleoside Transporters of Mammalian Cells. Pharmaceutical biotechnology. 12. 313–352. 102 indexed citations
7.
Yao, Sylvia Y.M., Amy M.L. Ng, Mark F. Vickers, et al.. (2002). Functional and Molecular Characterization of Nucleobase Transport by Recombinant Human and Rat Equilibrative Nucleoside Transporters 1 and 2. Journal of Biological Chemistry. 277(28). 24938–24948. 141 indexed citations
8.
Vickers, Mark F., James D. Young, Stephen A. Baldwin, Michael J. Ellison, & Carol E. Cass. (2001). Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae. Molecular Membrane Biology. 18(1). 73–79. 1 indexed citations
9.
Vickers, Mark F., James D. Young, Stephen A. Baldwin, Michael J. Ellison, & Carol E. Cass. (2001). Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae.. PubMed. 18(1). 73–9. 10 indexed citations
10.
Vickers, Mark F., James D. Young, Stephen A. Baldwin, Michael J. Ellison, & Carol E. Cass. (2001). Functional production of mammalian concentrative nucleoside transporters inSaccharomyces cerevisiae. Molecular Membrane Biology. 18(1). 73–79. 6 indexed citations
11.
Vickers, Mark F., Sylvia Y.M. Yao, Stephen A. Baldwin, James D. Young, & Carol E. Cass. (2000). Nucleoside Transporter Proteins of Saccharomyces cerevisiae. Journal of Biological Chemistry. 275(34). 25931–25938. 69 indexed citations
12.
Vickers, Mark F., James D. Young, Stephen A. Baldwin, John R. Mackey, & Carol E. Cass. (2000). Nucleoside transporter proteins: emerging targets for drug discovery. 4(4). 515–539. 18 indexed citations
13.
Vickers, Mark F., Rajam S. Mani, Manickavasagam Sundaram, et al.. (1999). Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Biochemical Journal. 339(1). 21–32. 88 indexed citations
14.
Vickers, Mark F., Rajam S. Mani, Manickavasagam Sundaram, et al.. (1999). Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Biochemical Journal. 339(1). 21–21. 18 indexed citations
15.
Hogue, Douglas L., Michael J. Ellison, Mark F. Vickers, & Carol E. Cass. (1997). Functional Complementation of a Membrane Transport Deficiency inSaccharomyces cerevisiaeby Recombinant ND4 Fusion Protein. Biochemical and Biophysical Research Communications. 238(3). 811–816. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026